
AdventHealth research contributes to approval of first FDA-approved drug to delay onset of Type 1 diabetes
After nearly 10 years as part of the TrialNet studies, physicians at AdventHealth Central Florida Division are now administering the world’s first treatment to delay the onset of Type 1 diabetes (T1D)...